Technology-enabled healthcare provider sees PAT surge 41% amid increased US outsourcing demand. Integrated platform adoption drives margin expansion to 35% for the quarter.<\/p>\n\n\n\n
Inventurus Knowledge Solutions Limited (NSE: IKS), a technology-enabled healthcare solutions provider, reported a 24% year-over-year increase in revenue for the third quarter of fiscal year 2026. The company\u2019s Care Enablement Platform, which supports physician enterprises in the United States, recorded a Profit After Tax (PAT) surge of 41% year-over-year.<\/p>\n\n\n\n
Founded in 2006, IKS Health operates a comprehensive healthcare enablement platform designed to reduce administrative and clinical burdens for provider organizations. The business model focuses on adding a technology-enabled layer to the care delivery pyramid, delegating chores across the patient journey to optimize revenue and reduce expenses for physician enterprises. The company employs 13,350 personnel, including over 2,000 clinically trained staff and 542 technology-focused employees as of December 31, 2025.<\/p>\n\n\n\n
For Q3 FY26, revenue from operations reached INR 8,150 million, representing 24% year-over-year growth in INR and 19% in USD. EBITDA grew 40% year-over-year to INR 2,816 million, with a margin of 34.6%. Profit After Tax for the period was INR 1,833 million, reflecting a PAT margin of 22.5%. The company reported a globally diversified workforce with 45% women employees.<\/p>\n\n\n\n
The company\u2019s growth is driven by its Scribble Suite for ambient clinical documentation and its Revenue Cycle Management (RCM) services. In Q3 FY26, IKS Health expanded its long-standing partnership with VitalMD Group Holding and Femwell Group Health to include ambient solutions for over 800 providers. A new partnership was also established with StrideCare, a Texas-based multi-specialty group, covering middle and back-office RCM, clinical documentation, and coding. Additionally, the company expanded its RCM and Value-Based Care (VBC) partnership with a top 5 US health system to include more regions.<\/p>\n\n\n\n
The company\u2019s strategy is built on five pillars: an AI-native agentic platform, AQuity acquisition integration, feature leadership, a differentiated growth market strategy, and an evolution toward an outcome-oriented model. IKS Health is advancing its AI capabilities by moving its patient engagement suite toward multi-agent orchestration for independent action. The integration of AQuity has successfully contributed to margin expansion and cross-selling.<\/p>\n\n\n\n
The company maintains a strong margin profile and reports high cash generation, with Q3 FY26 Operating Cash Flow (OCF) at INR 2,853 million and Free Cash Flow (FCF) at INR 1,970 million. Net debt has been reduced from INR 8,507 million in March 2024 to INR 3,220 million as of December 31, 2025. Return on Equity (ROE) remains high at 29.8%.<\/p>\n\n\n\n
The US healthcare market, with expenditures reaching US5trillionin2024,presentsaTotalAddressableMarket(TAM)ofUS260 billion for care enablement services. The outsourced market is expected to grow at a 12% CAGR through 2028. Management indicates that stagnant reimbursement rates in the US are acting as a catalyst for increased outsourcing and platform adoption.<\/p>\n\n\n\n
The company reached a significant regulatory milestone with its listing on the NSE and BSE in late 2024. Management noted that the Q3 performance validates the platform as a critical solution for cost and quality pressures in the US market.<\/p>\n\n\n\n
IKS Health has demonstrated a decade of consistent growth, with a 27.9% revenue CAGR and 32.3% PAT CAGR from 2016 to 2025. For the nine months ended December 31, 2025, revenue reached INR 23,361 million, a 20.4% increase over the previous year, while adjusted PAT for the same period rose 50.8%.<\/p>\n\n\n\n
IKS Health currently serves over 450 enterprise-level customers, with more than 90% of revenue derived from repeat clients. It is recognized as a market leader, ranked #1 in AI-driven RCM and medical coding by Blackbook, and recognized by KLAS Research for virtual scribing services. The top 10 clients have an average vintage of over 6.6 years, contributing 48.4% of total revenue.<\/p>\n","protected":false},"excerpt":{"rendered":"
Technology-enabled healthcare provider sees PAT surge 41% amid increased US outsourcing demand. Integrated platform adoption drives margin expansion to 35% for the quarter. Inventurus Knowledge Solutions Limited (NSE: IKS), a technology-enabled healthcare solutions provider, reported a 24% year-over-year increase in revenue for the third quarter of fiscal year 2026. The company\u2019s Care Enablement Platform, which […]<\/p>\n","protected":false},"author":2385,"featured_media":125416,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1941,5747],"tags":[15828,15821,15823,15822,15829,15827,15820,15825,15817,15830,15826,15818,15819,15824],"class_list":["post-179688","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-stock-analysis","category-healthcare-stocks","tag-iks","tag-iks-q1","tag-iks-q2","tag-iks-q3","tag-iks-q4","tag-inventurus-knowledge-announcement","tag-inventurus-knowledge-earnings","tag-inventurus-knowledge-investor-relations","tag-inventurus-knowledge-management","tag-inventurus-knowledge-price","tag-inventurus-knowledge-q1","tag-inventurus-knowledge-solutions-ltd","tag-inventurus-knowledge-stocks","tag-inventurus-knowledge-ticker"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":179598,"url":"https:\/\/alphastreet.com\/india\/inventurus-knowledge-q3-fy26-earnings-results\/","url_meta":{"origin":179688,"position":0},"title":"Inventurus Knowledge Q3 FY26 Earnings Results","author":"Divyansh_Kasana","date":"February 5, 2026","format":false,"excerpt":"Executive Summary Inventurus Knowledge Solutions Ltd reported Q3FY26 revenues of \u20b9815 crore, up 24.05% YoY, with consolidated net profit increasing 40.77% to \u20b9183 crore. Healthcare care enablement platform growth, AI advancements, and new partnerships like StrideCare drove strong performance amid US market demand. Revenue & Growth Revenues expanded to \u20b9815\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/IKS.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/IKS.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/IKS.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/IKS.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/IKS.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/IKS.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":175188,"url":"https:\/\/alphastreet.com\/india\/inventurus-knowledge-solutions-ltd-iks-q3-2025-earnings-call-transcript\/","url_meta":{"origin":179688,"position":1},"title":"Inventurus Knowledge Solutions Ltd (IKS) Q3 2025 Earnings Call Transcript","author":"News desk","date":"January 22, 2026","format":false,"excerpt":"Inventurus Knowledge Solutions Ltd (NSE: IKS) Q3 2025 Earnings Call dated Feb. 06, 2025 Corporate Participants: Saransh Mundra \u2014 Associate Vice President, EVP Investor Relations Sachin Gupta \u2014 Whole-time Director and Chief Executive Officer Nithya Balasubramanian \u2014 Chief Financial Officer Analysts: Ruchi Mukija \u2014 Analyst Seema Nayak \u2014 Analyst Abhishek\u2026","rel":"","context":"In "Earnings Call Transcripts"","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":175186,"url":"https:\/\/alphastreet.com\/india\/inventurus-knowledge-solutions-ltd-iks-q1-2026-earnings-call-transcript\/","url_meta":{"origin":179688,"position":2},"title":"Inventurus Knowledge Solutions Ltd (IKS) Q1 2026 Earnings Call Transcript","author":"News desk","date":"January 22, 2026","format":false,"excerpt":"Inventurus Knowledge Solutions Ltd (NSE: IKS) Q1 2026 Earnings Call dated Aug. 01, 2025 Corporate Participants: Saransh Mundra \u2014 Investor Relations Sachin K. Gupta \u2014 Founder & Global Chief Executive Officer Unidentified Speaker Nithya Balasubramanian. \u2014 Chief Financial Officer Analysts: Sagar Dhawan \u2014 Analyst Srinath V \u2014 Analyst Ruchi Mukhija\u2026","rel":"","context":"In "Earnings Call Transcripts"","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":181536,"url":"https:\/\/alphastreet.com\/india\/inventurus-knowledge-solutions-ltd-iks-q3-2026-earnings-call-transcript\/","url_meta":{"origin":179688,"position":3},"title":"Inventurus Knowledge Solutions Ltd (IKS) Q3 2026 Earnings Call Transcript","author":"News desk","date":"April 6, 2026","format":false,"excerpt":"Inventurus Knowledge Solutions Ltd (NSE: IKS) Q3 2026 Earnings Call dated Feb. 05, 2026 Corporate Participants: Saransh Mundra \u2014 Head of Investor Relations Sachin K. Gupta \u2014 Founder and Global Chief Executive Officer Nithya Balasubramanian \u2014 Group Chief Financial Officer Analysts: Seema Nair \u2014 Analyst Chirag Kachhadiya \u2014 Analyst Ruchi\u2026","rel":"","context":"In "Earnings Call Transcripts"","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":175187,"url":"https:\/\/alphastreet.com\/india\/inventurus-knowledge-solutions-ltd-iks-q4-2025-earnings-call-transcript\/","url_meta":{"origin":179688,"position":4},"title":"Inventurus Knowledge Solutions Ltd (IKS) Q4 2025 Earnings Call Transcript","author":"News desk","date":"January 22, 2026","format":false,"excerpt":"Inventurus Knowledge Solutions Ltd (NSE: IKS) Q4 2025 Earnings Call dated May. 16, 2025 Corporate Participants: Unidentified Speaker Saransh Mundra \u2014 Investor Relations Sachin Gupta \u2014 Chief Executive Officer, Whole Time Director Nithya Balasubramanian \u2014 Chief Financial Officer Analysts: Unidentified Participant Ruchi Mukhija \u2014 Analyst Sameer Shah \u2014 Analyst Srivathsan\u2026","rel":"","context":"In "Earnings Call Transcripts"","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/Transcript-thumbnail.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":171334,"url":"https:\/\/alphastreet.com\/india\/indegene-leading-digital-life-sciences-transformation\/","url_meta":{"origin":179688,"position":5},"title":"Indegene: Leading Digital Life Sciences Transformation","author":"Divyansh_Kasana","date":"September 22, 2025","format":false,"excerpt":"Company Overview: Indegene Ltd. positions itself as an indispensable enabler for digital-first transformation in the global life sciences arena. As a specialized partner to leading pharma and biotech clients, Indegene\u2019s suite of proprietary AI\/cloud-enabled solutions, next-generation analytics, deep clinical expertise, and end-to-end engagement platforms address critical needs in digital commercialization,\u2026","rel":"","context":"In "Research Summary"","block_context":{"text":"Research Summary","link":"https:\/\/alphastreet.com\/india\/category\/research-summary\/"},"img":{"alt_text":"Indegene","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/iStock-981901768.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/iStock-981901768.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/iStock-981901768.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/iStock-981901768.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179688","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/2385"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=179688"}],"version-history":[{"count":1,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179688\/revisions"}],"predecessor-version":[{"id":179689,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/179688\/revisions\/179689"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/125416"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=179688"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=179688"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=179688"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}